- Home
- ABOS vs TSE Comparison
ABOS vs TSE Comparison
Compare ABOS & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- TSE
- Stock Information
- Founded
- ABOS 1996
- TSE 2010
- Country
- ABOS United States
- TSE United States
- Employees
- ABOS N/A
- TSE 2950
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- TSE Major Chemicals
- Sector
- ABOS Health Care
- TSE Industrials
- Exchange
- ABOS Nasdaq
- TSE Nasdaq
- Market Cap
- ABOS 84.2M
- TSE 91.0M
- IPO Year
- ABOS 2021
- TSE 2014
- Fundamental
- Price
- ABOS $1.25
- TSE $2.45
- Analyst Decision
- ABOS Strong Buy
- TSE
- Analyst Count
- ABOS 3
- TSE 0
- Target Price
- ABOS $8.00
- TSE N/A
- AVG Volume (30 Days)
- ABOS 185.0K
- TSE 216.5K
- Earning Date
- ABOS 11-11-2025
- TSE 11-05-2025
- Dividend Yield
- ABOS N/A
- TSE 1.58%
- EPS Growth
- ABOS N/A
- TSE N/A
- EPS
- ABOS N/A
- TSE N/A
- Revenue
- ABOS N/A
- TSE $3,258,300,000.00
- Revenue This Year
- ABOS N/A
- TSE N/A
- Revenue Next Year
- ABOS N/A
- TSE $4.84
- P/E Ratio
- ABOS N/A
- TSE N/A
- Revenue Growth
- ABOS N/A
- TSE N/A
- 52 Week Low
- ABOS $0.86
- TSE $1.90
- 52 Week High
- ABOS $3.36
- TSE $7.05
- Technical
- Relative Strength Index (RSI)
- ABOS 41.32
- TSE 49.59
- Support Level
- ABOS $1.21
- TSE $2.34
- Resistance Level
- ABOS $1.47
- TSE $2.55
- Average True Range (ATR)
- ABOS 0.08
- TSE 0.15
- MACD
- ABOS -0.02
- TSE 0.03
- Stochastic Oscillator
- ABOS 15.38
- TSE 44.19
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.